ScreenerHero

ANNX Annexin Pharmaceuticals AB (publ)

STO · SE · Healthcare · Biotechnology · annexinpharma.se
8.760SEK-2.01%Mkt Cap: 7.31M $P/E: —

Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natu…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap7.31M USD
Enterprise Value5.53M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.53M USD
Revenue/Share—
Last Price8.760 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0025159387
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.41
EV/Revenue—
P/S—
P/B25.04
EPS (TTM)-6.20
EPS (Forward)—
52W Range
8.5401% of range29.80
52W High29.80 SEK
52W Low8.540 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-147.97%
ROA-122.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.53M USD
CapEx (TTM)12.34K USD
FCF Margin—
FCF Yield-31.22%
Net Debt-504.28K USD
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity0.00
Current Ratio1.19
Quick Ratio1.08
Book Value/Sh0.36 SEK
Cash/Share0.75 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateMay 28, 2025
Analyst Consensus
Rating—
Target (Mean)61.00 SEK
Upside (mean)+596.3%
Target Range61.00 SEK – 61.00 SEK
# Analysts1
Ownership
Shares Out.8.72M
Float3.14M
Insiders54.97%
Institutions4.71%
Technical
SMA 5012.11 (-27.7%)
SMA 20014.02 (-37.5%)
Beta0.38
S&P 52W Chg16.45%
Avg Vol (30d)11.61K
Avg Vol (10d)14.04K
Technical Indicators
RSI (14)23.7
MACD-1.0513
MACD Signal-0.9670
MACD Hist.-0.0843
BB Upper13.97 SEK
BB Middle10.44 SEK
BB Lower6.909 SEK
BB Width67.66%
ATR (14)0.5448 SEK
Vol Ratio (20d)0.17x